High-Content Screening with siRNA Optimizes a Cell Biological Approach to Drug Discovery: Defining the Role of P53 Activation in the Cellular Response to Anticancer Drugs
Open Access
- 1 October 2004
- journal article
- Published by Elsevier in SLAS Discovery
- Vol. 9 (7) , 557-568
- https://doi.org/10.1177/1087057104265387
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- High content screening applied to large-scale cell biologyTrends in Biotechnology, 2004
- Advances in High Content Screening for Drug DiscoveryASSAY and Drug Development Technologies, 2003
- Functional genomics and proteomics: charting a multidimensional map of the yeast cellTrends in Cell Biology, 2003
- The Human Phenome ProjectNature Genetics, 2003
- A vision for the future of genomics researchNature, 2003
- The Human Genome Project: Lessons from Large-Scale BiologyScience, 2003
- High-Content Profiling of Drug-Drug Interactions: Cellular Targets Involved in the Modulation of Microtubule Drug Action by the Antifungal KetoconazoleSLAS Discovery, 2003
- New technologies to assess genotype–phenotype relationshipsNature Reviews Genetics, 2003
- Challenges for Biomedical Informatics and PharmacogenomicsAnnual Review of Pharmacology and Toxicology, 2002
- High-Content Screening: A New Approach to Easing Key Bottlenecks in the Drug Discovery ProcessSLAS Discovery, 1997